Mr Mrs Miss Ms Dr Other

Dr
Mat
Pringle

Senior Patent Attorney

Leeds Office

Chemistry

Telephone. +44(0) 113 233 0100
Email. mpringle@hgf.com
Vcard
Linkedin

Experience

Mat handles the drafting and prosecution of patent applications across a wide range of chemical subject matter, including pharmaceuticals and pharmaceutical formulations, agrochemicals, alloys, medical devices, functionalised surfaces and surface coatings, and nano-materials.

Mat has a First Class Masters Degree in Chemistry from the University of Sheffield, as well as a PhD in Surface Chemistry from the same institution. His doctoral research focussed on the development of self-assembled monolayers and their potential to create molecular-scale structures on surfaces.

Specialisms

Industries

Services

Qualifications

Patent Attorney

Chartered (UK)
Europe

MCHEM

First Class, University of Sheffield (2010)

PHD

Nanochemistry / Surface Chemistry, University of Sheffield (2014)

Related News

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

G1/23: The Enlarged Board of Appeal shift EPO practice towards an “on-sale” bar.

Last week, the EPO’s Enlarged Board of Appeal (EBA) issued its Decision that both a product put on the market before the date of filing of a European patent application, …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

Seminar on Incorporating Trade Secrets into your IP Strategy

HGF is hosting a Seminar on Incorporating Trade Secrets into your IP Strategy which will be followed by networking, apero, and snacks. The Seminar will be held on Wednesday, 10th …

Read article

Providing Enabling Disclosure for AI inventions at the EPO

  Video overview: The equivalent to the enablement requirement in the US at the EPO is Sufficiency. There is an increasing trend for the sufficiency of AI related patent applications …

Read article

Precision Medicine Patenting of Known Drugs for Known Indications at the EPO

Video overview: The identification of specific sub-groups of patients to treat with a known drug, even if said patients may have been treated before with the drug, can yield patentable …

Read article

Novelty Over Clinical Trials at the EPO

Video overview: Second medical use claims can be novel over clinical trials in European patents.  Typically, such a claim would be fairly narrow, e.g. perhaps mapping onto specific indications and …

Read article
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us